APA (7th ed.) Citation

E, P., HJ, K., AL, L., L, S., S, S., WF, G., . . . CH, C. (2026). IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in glioma. Nature communications. https://doi.org/10.1038/s41467-026-73974-5

Chicago Style (17th ed.) Citation

E, Panagioti, et al. "IDH1-R132H Enhances Oncolytic HSV-1 Therapy by Facilitating Viral Entry and Immune Activation in Glioma." Nature Communications 2026. https://doi.org/10.1038/s41467-026-73974-5.

MLA (9th ed.) Citation

E, Panagioti, et al. "IDH1-R132H Enhances Oncolytic HSV-1 Therapy by Facilitating Viral Entry and Immune Activation in Glioma." Nature Communications, 2026, https://doi.org/10.1038/s41467-026-73974-5.